Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 100033
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.100033
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.100033
Table 2 2D-shear wave elastography diagnostic efficacy (area under the receiver operating characteristic curves for fibrosis detection)
Ref. | Number of patients | Disease/diagnose | Diagnostic method | Fibrosis stage | AUROC (CI) | Assessment |
Fang et al[25] | 121 | CLD | 2D-SWE | F ≥ 2 | 0.884 (0.817-0.951) | Good |
F ≥ 3 | 0.926 (0.88-0.973) | Excellent | ||||
Aksakal et al[20] | 103 | CHB/CHC | 2D-SWE | F ≥ 1 | 0.85 (0.75-0.94) | Good |
F ≥ 2 | 0.98 (0.94-1.00) | Excellent | ||||
F ≥ 3 | 0.97 (0.94-1.00) | Excellent | ||||
F ≥ 4 | 0.94 (0.89-1.00) | Excellent | ||||
Alcantara-Diaz et al[21] | 227 | Obesity | 2D-SWE | F ≥ 2 | 0.54 (0.47-0.62) | Unacceptable |
F ≥ 3 (whole) | 0.73 (0.60-0.87) | Acceptable | ||||
F ≥ 3 (women) | 0.82 (0.59-1.00) | Good | ||||
F ≥ 3 (morbid obesity) | 0.78 (0.61-0.99) | Acceptable | ||||
Imajo et al[66] | 231 | NAFLD | 2D-SWE | F4 | 0.88 (0.83-0.92) | Good |
Jocius et al[28] | 72 | CLD | 2D-SWE | F1 vs F2-F4 | 0.75 | Acceptable |
F1-F2 vs F3-F4 | 0.93 | Excellent | ||||
F1-F3 vs F4 | 0.91 | Excellent | ||||
Lee et al[31] | 87 | CLD | 2D-SWE | ≥ F2 | 0.965 (0.895-0.993) | Excellent |
F4 | 0.994 (0.943-1.00) | Excellent | ||||
Manesis et al[32] | 53 | PBC | 2D-SWE | F1 | 0.874 | Good |
F2 | 0.853 | Good | ||||
F3 | 0.953 | Excellent | ||||
F4 | 0.953 | Excellent | ||||
Martonik et al[33] | 231 | HBV/HCV | 2D-SWE | F0-F1 vs ≥ F2 | 0.83 | Good |
F2 vs ≥ F3 | 0.84 | Good | ||||
F3 vs F4 | 0.94 | Excellent | ||||
Mendoza et al[34] | 200 | NAFLD | 2D-SWE | ≥ F2 | 0.83 (0.72-0.93) | Good |
≥ F3 | 0.84 (0.76-0.92) | Good | ||||
F4 | 0.94 (0.89-0.99) | Excellent | ||||
Paisant et al[38] | 788 | Liver fibrosis | 2D-SWE | >F2 | 0.825 (SD ± 0.006) | Good |
F4 | 0.880 (SD ± 0.006) | Good | ||||
Prieto Ortiz et al[68] | 453 | Liver fibrosis | 2D-SWE | F > 1 | 0.75 | Acceptable |
F > 2 | 0.83 | Good | ||||
F > 3 | 0.89 | Good | ||||
F = 4 | 0.94 | Excellent | ||||
Seyrek et al[42] | 146 | CLD | 2D-SWE | > F2 | 0.86 (0.75-0.96) | Good |
> F3 | 0.87 (0.78-0.97) | Good | ||||
F2-F4 | 0.84 (0.76-0.92) | Good | ||||
F4 | 0.93 (0.86-0.99) | Excellent | ||||
Sharpton et al[43] | 114 | CLD | 2D-SWE | F2-F4 | 0.84 (0.76-0.92) | Good |
F3-F4 | 0.88 (0.81-0.96) | Good | ||||
F4 | 0.93 (0.86-0.99) | Excellent | ||||
Soh et al[44] | 69 | AIH | 2D-SWE | ≥ F2 | 0.903 (0.807-0.961) | Excellent |
≥ F3 | 0.815 (0.703-0.898) | Good | ||||
F4 | 0.854 (0.748-0.927) | Good | ||||
Song et al[45] | 602 | CHB | 2D-SWE | ≥ F1 | 0.807 (0.742-0.861) | Good |
≥ F2 | 0.868 (0.810-0.914) | Good | ||||
≥ F3 | 0.855 (0.796-0.903) | Good | ||||
F4 | 0.851 (0.791-0.900) | Good | ||||
Wang et al[47] | 141 | AIH-PBC | 2D-SWE | F2-F4 | 0.748 (0.668-0.817) | Acceptable |
F3-F4 | 0.818 (0.745-0.878) | Good | ||||
F4 | 0.879 (0.813-0.928) | Good | ||||
Yan et al[69] | 148 | AIH-PBC | 2D-SWE | ≥ F2 | 0.91 (0.85-0.96) | Excellent |
≥ F3 | 0.97 (0.94-0.99) | Excellent | ||||
F4 | 0.96 (0.92-0.99) | Excellent | ||||
Yoo et al[52] | 115 | CLD | 2D-SWE | F2 | 0.851 (0.773-0.911) | Good |
F3 | 0.917 (0.851-0.960) | Excellent | ||||
F4 | 0.889 (0.817-0.940) | Good | ||||
Yamaoka et al[54] | 116 | CLD | 2D-SWE | ≥ F2 | 0.85 (0.773-0.911) | Good |
≥ F3 | 0.91 (0.81-0.97) | Excellent | ||||
F4 | 0.88 (0.79-1.00) | Good | ||||
Zhou et al[64] | 116 | NAFLD | 2D-SWE | ≥ F2 | 0.86 (0.77-0.94) | Good |
≥ F3 | 0.89 (0.81-0.97) | Good | ||||
F4 | 0.90 (0.79-1.00) | Good |
- Citation: Pozowski P, Bilski M, Bedrylo M, Sitny P, Zaleska-Dorobisz U. Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison. World J Hepatol 2025; 17(2): 100033
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/100033.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.100033